Related Experiment Video
Updated: Feb 15, 2026

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
Published on: November 1, 2018
Microparticles as prognostic biomarkers in dengue virus infection
Rucha Patil1, Smrati Bajpai2, Kanjaksha Ghosh3
1National Institute of Immunohaematology (ICMR), 13th Floor, KEM Hospital, Parel, Mumbai 400 012, India.
Abstract:
Promising biomarkers which may help predict the risk of developing severe dengue virus infection (DVI) are lacking and will be helpful. Thus the main aim of this study was to analyze the role of cell-derived microparticles (MP) in DVI. Sixty patients with DVI i.e. 18: dengue with warning signs (DWS); 1: DSS and 41: dengue without warning signs (DWOS); along with 15 controls (other febrile illness) were included in the study. The following MPs were assessed: annexinV, platelet (CD41a), red blood cell (RBC) (CD235a) and activated endothelial (CD62e) MPs. Patients with profound thrombocytopenia without bleeding had statistically elevated platelet MP (PMP) levels when compared to patients with profound thrombocytopenia with bleeding (p < .001). RBC MPs were found to be significantly elevated in the 2nd phase in patient with DWS which was seen earliest on day 4 of infection with a cut off of ≥2200 MPs/μl when compared to patients with DWOS (p < .0001). PMPs may prove to be a promising novel biomarker which helps discriminate patients in need of prophylactic platelet transfusion from those who do not. RBC MPs, on the other hand could be potential biomarkers capable of identifying potentially severe patients who require immediate care. Thus, MPs seem to be a promising important biomarker in many aspects of DVI.
Insights
Cell-derived microparticles (MPs) show promise as biomarkers for dengue virus infection (DVI). Platelet MPs may guide transfusion decisions, while red blood cell MPs could identify severe cases needing immediate care.
Area of Science:
- Virology
- Immunology
- Hematology
Background:
- Predicting severe dengue virus infection (DVI) requires reliable biomarkers.
- Cell-derived microparticles (MPs) are emerging as potential indicators in various diseases.
Purpose of the Study:
- To investigate the role of microparticles (MPs) in dengue virus infection (DVI).
- To assess specific MPs as potential biomarkers for DVI severity and patient management.
Main Methods:
- Analyzed annexinV, platelet (CD41a), red blood cell (RBC) (CD235a), and activated endothelial (CD62e) MPs.
- Compared MP levels in 60 DVI patients (including dengue with warning signs, dengue shock syndrome, and dengue without warning signs) and 15 controls.
Main Results:
- Elevated platelet MP (PMP) levels in patients with profound thrombocytopenia without bleeding versus those with bleeding (p < .001).
- Significantly higher RBC MPs in the second phase of DWS patients by day 4 (≥2200 MPs/μl) compared to DWOS patients (p < .0001).
Conclusions:
- Platelet MPs could be novel biomarkers to differentiate patients requiring prophylactic platelet transfusion.
- RBC MPs may identify severe dengue cases needing urgent medical attention.
- Microparticles show significant potential as biomarkers across various aspects of DVI.
Related Concept Videos
What are Viruses?
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Introduction to Virus
Viruses of Archaea
Viruses with RNA Genomes

